lancet-header

Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com.

A Prospective Observational Study of Acute Traumatic Coagulopathy in in Traumatic Bleeding from the Battlefield

28 Pages Posted: 19 Jul 2018

See all articles by Tom Woolley

Tom Woolley

Government of the United Kingdom - Royal Centre for Defence Medicine

Kiran Parmar

National Health Service (NHS), St. Thomas Hospital, Thrombosis and Vascular Biology Group

Emrys Kirkman

Government of the United Kingdom, Ministry of Defence, Defence Science and Technology Laboratory, CBR Division

Sarah Watts

Government of the United Kingdom, Ministry of Defence, Defence Science and Technology Laboratory, CBR Division

Robert Gwyther

Government of the United Kingdom, Ministry of Defence, Defence Science and Technology Laboratory, CBR Division

Mark Midwinter

University of Queensland, Faculty of Medicine, School Biomedical Science

Jurandir J. Dalle Lucca

DL Resolution, LLC

Beverley J. Hunt

National Health Service (NHS), St. Thomas Hospital, Thrombosis & Haemophilia Centre

More...

Abstract

Background  Acute trauma coagulopathy (ATC) is defined by an admission prothrombin time ratio (PTr) >1.2 or reduced clot amplitude, on viscoelastic testing. It is associated with increased mortality. Whether ATC occurs after military trauma and whether it is similar to civilian ATC has not been studied. Military trauma differs from civilian trauma with most injuries from explosions and high velocity gun-shot wounds (GSW).  This study aimed to characterize military ATC, and to explore possible differences due to the mechanism of injury.

Methods: Casualties meeting full trauma team activation on admission to a military field hospital in Afghanistan were eligible for enrollment. After routine blood sampling, waste plasma was prepared, frozen and transported to the UK for further analysis.  Findings  77% had ATC as defined by PTr >1.2; only 19% had ATC as defined by a ROTEM A5<36mmHg. Coagulation factor levels correlated with degree of shock, with Factor V (p<0.0001), Factor X (p<0.004) and fibrinogen (p=0.005) showing lower levels. Despite reduced coagulation factors, thrombin generation was well preserved. Fibrinolytic markers (plasmin- antiplasmin (PAP), D-dimer and tissue plasminogen activator levels (tPa)) were increased, correlating with the degree of shock.  PAP (p<0.0001) and D Dimer (p=0.0008) levels were greater in those injured by explosion compared to GSW's. Only 8% of casualties had ROTEM hyperfibrinolysis.

Interpretations: Military trauma causes ATC and is associated with the extent of injury and shock, similar  to civilian trauma. This finding means civilian and military treatments can inform each other. Thrombin generation remained normal or high suggesting that ATC is not due coagulation failure. Fibrinogen and FV levels were disproportionately lowered. Fibrinolysis is a key feature, potentially due in part to a tPa surge at the time of injury. Blast injury caused more activation of fibrinolysis than GSW, a novel finding.

Funding: Funding was from the Ministry of Defense  .

Conflict of Interests: There are no conflicts of interest to declare.

Ethics Approval Statement: We utilized residual plasma after routine coagulation testing on admission. As this volume was of negligible amount in relation to the patients’ blood loss, a formal ethics submission was not required by the UK Ministry of Defense Research Ethics Committee. The USA army granted ethical approval (log number M-10242) for their study participants. Both agreed that informed consent was not required as this study was a minimal risk to the subjects.

Suggested Citation

Woolley, Tom and Parmar, Kiran and Kirkman, Emrys and Watts, Sarah and Gwyther, Robert and Midwinter, Mark and Dalle Lucca, Jurandir J. and Hunt, Beverley J., A Prospective Observational Study of Acute Traumatic Coagulopathy in in Traumatic Bleeding from the Battlefield (April 7, 2018). Available at SSRN: https://ssrn.com/abstract=3208359 or http://dx.doi.org/10.2139/ssrn.3208359

Tom Woolley (Contact Author)

Government of the United Kingdom - Royal Centre for Defence Medicine ( email )

Birmingham
United Kingdom

Kiran Parmar

National Health Service (NHS), St. Thomas Hospital, Thrombosis and Vascular Biology Group

London
United Kingdom

Emrys Kirkman

Government of the United Kingdom, Ministry of Defence, Defence Science and Technology Laboratory, CBR Division

Salisury
United Kingdom

Sarah Watts

Government of the United Kingdom, Ministry of Defence, Defence Science and Technology Laboratory, CBR Division

Salisury
United Kingdom

Robert Gwyther

Government of the United Kingdom, Ministry of Defence, Defence Science and Technology Laboratory, CBR Division

Salisury
United Kingdom

Mark Midwinter

University of Queensland, Faculty of Medicine, School Biomedical Science

QLD
Brisbane, Queensland 4072
Australia

Jurandir J. Dalle Lucca

DL Resolution, LLC

VA
United States

Beverley J. Hunt

National Health Service (NHS), St. Thomas Hospital, Thrombosis & Haemophilia Centre

London
United Kingdom